Guillermo E.

Guillermo E. serves as the President and Chief Executive Officer of Proximity Therapeutics, Inc., overseeing the discovery and development of innovative medicines for neurological and neurodegenerative diseases since September 2022. In addition to this role, Guillermo E. is an Executive Mentor for the WBCSD LEAP Program, focusing on sustainable development. Prior experience includes leadership as CEO and Chief Business Officer at Molecular Stethoscope (now Superfluid Dx, Inc.), where efforts centered on precision medicine and chronic disease monitoring. Guillermo E. has held various strategic positions in renowned companies such as Corvus Pharmaceuticals and Roche, contributing to product management, investor relations, and corporate development. Academic credentials include advanced degrees from Stanford University, IE Business School, and UCSF, complemented by research at Cold Spring Harbor Laboratory.